UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000012763
Receipt No. R000014903
Official scientific title of the study Clinical evaluation of the safety and the usefulness of robot assisted distal gastrectomy with D2 lymphadenectomy for gastric cancer
Date of disclosure of the study information 2014/01/08
Last modified on 2016/07/06 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Clinical evaluation of the safety and the usefulness of robot assisted distal gastrectomy with D2 lymphadenectomy for gastric cancer
Title of the study (Brief title) Clinical evaluation of the safety of RADG with D2
Region
Japan

Condition
Condition gastric cancer
Classification by specialty
Gastrointestinal surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the safety and the usefulness of robot assisted distal gastrectomy with D2
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes The incidence of post-operative complications (anastomotic leakage, pancreas related infection, and intra-abdominal abscess)
Key secondary outcomes Completion rate of robot assised surgery
The incidence of adverse event

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 Robot assisted surgery
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)Over 20 years of age
2)Survival 12 months or more expected
3)Distal gastrectomy
4)Performance Status PS0-1
5)Provision of written informed consent
Key exclusion criteria 1)Severer adhision in abdominal cavity
2)Possibly pregnant or breast feeding woman
3)In case of malignant cells or intraperitoneal seeding are observed
4)Other, if the principal investigator has been deemed inappropriate
Target sample size 10

Research contact person
Name of lead principal investigator Satoshi Hirano
Organization Hokkaido University Graduate School of Medicine
Division name Department of Gastroenterological Surgery II
Address W7, N7, Kita-ku, Sapporo, Hokkaido Japan
TEL 011-706-7714
Email satto@med.hokudai.ac.jp

Public contact
Name of contact person Yuma Ebihara
Organization Hokkaido University Graduate School of Medicine
Division name Department of Gastroenterological Surgery II
Address W7, N7, Kita-ku, Sapporo, Hokkaido Japan
TEL 011-706-7714
Homepage URL
Email yuma-ebi@wc4.so-net.ne.jp

Sponsor
Institute Hokkaido University Graduate School of Medicine
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 北海道大学医学部付属病院(北海道)

Other administrative information
Date of disclosure of the study information
2014 Year 01 Month 08 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 10 Month 10 Day
Anticipated trial start date
2014 Year 01 Month 06 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 01 Month 06 Day
Last modified on
2016 Year 07 Month 06 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000014903